| scholarly article | Q13442814 |
| P50 | author | Irena Baranowska-Bosiacka | Q42305549 |
| Dariusz Chlubek | Q41532339 | ||
| Izabela Gutowska | Q59541582 | ||
| Jan Korbecki | Q59691236 | ||
| Agnieszka Łukomska | Q59691284 | ||
| Marta Goschorska | Q60968412 | ||
| Dariusz Jeżewski | Q94555958 | ||
| P2093 | author name string | Anna Lubkowska | |
| Ireneusz Kojder | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 | Q24336131 | ||
| Targeting energy metabolism in brain cancer: review and hypothesis | Q24537119 | ||
| Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype | Q24631473 | ||
| Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells | Q24654005 | ||
| The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes | Q24675696 | ||
| Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence | Q26752466 | ||
| Glioma Stem Cells: Signaling, Microenvironment, and Therapy | Q26765854 | ||
| Immune Evasion Strategies of Glioblastoma | Q26765855 | ||
| Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites | Q26798402 | ||
| Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells | Q26801288 | ||
| Cancer stem cells--important players in tumor therapy resistance | Q26823015 | ||
| Sphingosine-1-phosphate modulates dendritic cell function: focus on non-migratory effects in vitro and in vivo | Q26825611 | ||
| EGFR Amplification and Glioblastoma Stem-Like Cells | Q26853549 | ||
| Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy | Q26998111 | ||
| HLA-dependent tumour development: a role for tumour associate macrophages? | Q27022124 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment | Q28069459 | ||
| The CXCL8-CXCR1/2 pathways in cancer | Q28075994 | ||
| Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma | Q28087306 | ||
| NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway | Q28114786 | ||
| Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells | Q28204518 | ||
| Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia | Q28211177 | ||
| Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents | Q28215555 | ||
| Neurotensin counteracts apoptosis in breast cancer cells | Q28216514 | ||
| Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice | Q28239258 | ||
| Seroprevalence of cytomegalovirus infection in the United States, 1988-1994 | Q28267544 | ||
| Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization | Q28293429 | ||
| Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720 | Q28512961 | ||
| Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor | Q28534550 | ||
| Opposing effects of PI3K/Akt and Smad-dependent signaling pathways in NAG-1-induced glioblastoma cell apoptosis | Q28538175 | ||
| Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma | Q28541502 | ||
| Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation | Q28564261 | ||
| Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas | Q28564777 | ||
| Cytoskeleton-related trafficking of the EAAC1 glutamate transporter after activation of the G(q/11)-coupled neurotensin receptor NTS1 | Q28579949 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma | Q29615604 | ||
| THE METABOLISM OF TUMORS IN THE BODY | Q29616202 | ||
| On respiratory impairment in cancer cells | Q29617276 | ||
| Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists | Q29618071 | ||
| Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. | Q30366921 | ||
| CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. | Q30402063 | ||
| A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. | Q30408967 | ||
| Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses | Q37123220 | ||
| Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? | Q37132414 | ||
| Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen | Q37141399 | ||
| Roles of neural stem progenitor cells in cytomegalovirus infection of the brain in mouse models | Q37145096 | ||
| Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV) | Q37149865 | ||
| Control of apoptosis by human cytomegalovirus. | Q37220001 | ||
| Antiviral strategies to combat cytomegalovirus infections in transplant recipients | Q37229010 | ||
| Recent advances and future of immunotherapy for glioblastoma | Q37239071 | ||
| Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61 | Q37255447 | ||
| Sphingosine kinases are not required for inflammatory responses in macrophages | Q37289270 | ||
| NF-kappaB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1/M2 polarization of monocytes | Q37329260 | ||
| EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells | Q37364683 | ||
| Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts | Q37364840 | ||
| The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment | Q37366259 | ||
| Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies | Q37382152 | ||
| Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation | Q37396541 | ||
| Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism | Q37417949 | ||
| The EGFRvIII variant in glioblastoma multiforme | Q37424448 | ||
| Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche | Q37433709 | ||
| Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas | Q37435455 | ||
| Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures | Q37463290 | ||
| Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow | Q37477918 | ||
| The Vps10p-domain receptor family. | Q37478180 | ||
| Role of hypoxia in the hallmarks of human cancer | Q37500308 | ||
| Biology of angiogenesis and invasion in glioma | Q37533625 | ||
| Regulation of macrophage function by sphingosine-1-phosphate. | Q37558824 | ||
| Cidofovir: a novel antitumor agent for glioblastoma | Q37574749 | ||
| HCMV reprogramming of infected monocyte survival and differentiation: a Goldilocks phenomenon | Q37611836 | ||
| Modulators of the Balance between M1 and M2 Macrophages during Pregnancy | Q37632944 | ||
| SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner | Q37662776 | ||
| Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma | Q37687730 | ||
| NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma | Q37688527 | ||
| A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology | Q37696591 | ||
| Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling | Q33842473 | ||
| A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury | Q33855120 | ||
| Human Cytomegalovirus Latency: Approaching the Gordian Knot | Q33912815 | ||
| Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells | Q33916859 | ||
| Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells | Q33967361 | ||
| Pleiotropic functions of plasminogen activator inhibitor-1. | Q33984228 | ||
| Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. | Q34017124 | ||
| Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells | Q34036069 | ||
| Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro | Q34059073 | ||
| Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1. | Q34076317 | ||
| Excess neutrophil infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice | Q34142783 | ||
| GDF-15/MIC-1 a novel member of the TGF-beta superfamily. | Q34155168 | ||
| Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model | Q34156527 | ||
| Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3. | Q34170538 | ||
| Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study | Q34198365 | ||
| The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. | Q34217756 | ||
| Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. | Q34227743 | ||
| Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases | Q34234281 | ||
| The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2 | Q34274256 | ||
| Human cytomegalovirus directly modulates expression of chemokine CCL2 (MCP-1) during viral replication | Q39111084 | ||
| Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity | Q39157456 | ||
| Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis. | Q39196377 | ||
| Focal adhesion kinase dependent activation of the PI3 kinase pathway by the functional soluble form of neurotensin receptor-3 in HT29 cells | Q39197267 | ||
| Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells | Q39198840 | ||
| Fingolimod phosphate promotes the neuroprotective effects of microglia | Q39216224 | ||
| Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2). | Q39218029 | ||
| Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients | Q39279856 | ||
| Engineering challenges for brain tumor immunotherapy | Q39381281 | ||
| Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase | Q39404395 | ||
| Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells. | Q39414795 | ||
| CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling | Q39459026 | ||
| Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study | Q39468197 | ||
| Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors | Q39497062 | ||
| CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes. | Q39507440 | ||
| Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. | Q39540948 | ||
| Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. | Q39568139 | ||
| Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1. | Q39601785 | ||
| Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures | Q39606146 | ||
| The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist | Q39616316 | ||
| Development of a sphingosine kinase 1 specific small-molecule inhibitor | Q39635785 | ||
| Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor | Q39652186 | ||
| Sphingosine 1-phosphate (S1P) induces expression of E-selectin and adhesion of monocytes via intracellular signalling pathways in vascular endothelial cells | Q39676270 | ||
| Human glioblastoma-associated microglia/monocytes express a distinct RNA profile compared to human control and murine samples. | Q39677282 | ||
| GDF-15 contributes to proliferation and immune escape of malignant gliomas | Q39695192 | ||
| Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors | Q39732445 | ||
| Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251. | Q39733779 | ||
| CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). | Q39735092 | ||
| CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. | Q39742087 | ||
| Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases | Q39751334 | ||
| Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. | Q39758728 | ||
| Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes. | Q39792977 | ||
| Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype | Q39823174 | ||
| Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling | Q39867520 | ||
| Activation of telomerase by human cytomegalovirus | Q39868592 | ||
| The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. | Q39868610 | ||
| Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. | Q39873122 | ||
| NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors | Q39889532 | ||
| Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression | Q34301906 | ||
| Experimental human cytomegalovirus latency in CD14+monocytes | Q34358864 | ||
| Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics. | Q34359722 | ||
| Detection of human cytomegalovirus in different histological types of gliomas | Q34402501 | ||
| Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study | Q34434118 | ||
| Human cytomegalovirus-encoded pUL7 is a novel CEACAM1-like molecule responsible for promotion of angiogenesis | Q34440895 | ||
| Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice | Q34483533 | ||
| Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib | Q34483541 | ||
| US28 is a potent activator of phospholipase C during HCMV infection of clinically relevant target cells | Q34500430 | ||
| Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus | Q34535736 | ||
| Emerging treatment strategies for glioblastoma multiforme | Q34542656 | ||
| Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism | Q34571684 | ||
| Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis | Q34581700 | ||
| FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3. | Q34635490 | ||
| Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells | Q34676029 | ||
| Sphingosine‐1‐phosphate antibodies as potential agents in the treatment of cancer and age‐related macular degeneration | Q34678040 | ||
| Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. | Q34721575 | ||
| Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy | Q34744555 | ||
| Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. | Q34748080 | ||
| COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells | Q34784887 | ||
| Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival | Q34797919 | ||
| A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors | Q34809705 | ||
| Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein | Q34868376 | ||
| The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells | Q34902490 | ||
| The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex | Q34916655 | ||
| Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity | Q35031305 | ||
| Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response | Q35043529 | ||
| Heterogeneity maintenance in glioblastoma: a social network | Q35050894 | ||
| Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy | Q35051499 | ||
| Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. | Q35058891 | ||
| Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion | Q35087191 | ||
| Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients | Q35092006 | ||
| DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines | Q35098017 | ||
| Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages | Q35118828 | ||
| Sphingosine 1-phosphate induces neutrophil chemoattractant IL-8: repression by steroids | Q35125221 | ||
| Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration | Q42081310 | ||
| Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. | Q42142782 | ||
| Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience | Q42180629 | ||
| Brain pharmacokinetics of ganciclovir in rats with orthotopic BT4C glioma | Q42182796 | ||
| Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. | Q42220581 | ||
| Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells | Q42235385 | ||
| Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues. | Q42248179 | ||
| Lack of presence of the human cytomegalovirus in human glioblastoma. | Q42249207 | ||
| Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization | Q42249769 | ||
| Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells. | Q42251801 | ||
| Human cytomegalovirus (HCMV) induces human endogenous retrovirus (HERV) transcription | Q42256195 | ||
| High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients | Q42258746 | ||
| Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis | Q42288906 | ||
| Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces | Q42292507 | ||
| Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study | Q42489739 | ||
| The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3). | Q42510506 | ||
| Improved neurotensin-vector-mediated gene transfer by the coupling of hemagglutinin HA2 fusogenic peptide and Vp1 SV40 nuclear localization signal. | Q42527255 | ||
| Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation. | Q42531590 | ||
| Neurotensin modulates the migratory and inflammatory response of macrophages under hyperglycemic conditions. | Q42574610 | ||
| FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction | Q42702313 | ||
| Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3. | Q42712745 | ||
| Cytomegalovirus cell tropism, replication, and gene transfer in brain | Q42807665 | ||
| SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism | Q42810891 | ||
| Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity | Q42817308 | ||
| HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis | Q42823931 | ||
| The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients | Q43236003 | ||
| Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival | Q43265790 | ||
| The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia | Q43283062 | ||
| The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo | Q43289465 | ||
| Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis | Q43432914 | ||
| Suppression of monocyte functions by human cytomegalovirus | Q43529795 | ||
| Human NK cells can control CMV infection in the absence of T cells | Q43537999 | ||
| CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. | Q43583466 | ||
| Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs | Q43851135 | ||
| Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc | Q43909535 | ||
| FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. | Q43971484 | ||
| The detection of CMV pp65 and IE1 in glioblastoma multiforme | Q44004603 | ||
| Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells | Q44012128 | ||
| The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. | Q44179291 | ||
| Survival in patients with glioblastoma receiving valganciclovir | Q44239157 | ||
| Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer | Q44455044 | ||
| Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients. | Q44608992 | ||
| The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors | Q44722923 | ||
| Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice | Q44777835 | ||
| Angiogenesis is not mediated by prostate cancer neuropeptides | Q44913083 | ||
| Human cytomegalovirus infection and expression in human malignant glioma. | Q44991512 | ||
| Human cytomegalovirus chemokine receptor US28 induces migration of cells on a CX3CL1-presenting surface | Q45011464 | ||
| The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas. | Q45048548 | ||
| S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3. | Q37706508 | ||
| Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. | Q37706595 | ||
| Differential S1P Receptor Profiles on M1- and M2-Polarized Macrophages Affect Macrophage Cytokine Production and Migration. | Q37711740 | ||
| Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer | Q37772662 | ||
| Human cytomegalovirus immunity and immune evasion | Q37807749 | ||
| The search for new therapies for human cytomegalovirus infections. | Q37811458 | ||
| Contribution of neurotensin in the immune and neuroendocrine modulation of normal and abnormal enteric function | Q37872839 | ||
| Targeting sphingosine-1-phosphate receptors in cancer | Q37894772 | ||
| Tumor-associated neutrophils: friend or foe? | Q37994480 | ||
| Diverse immune evasion strategies by human cytomegalovirus | Q37997733 | ||
| PDGF and PDGF receptors in glioma. | Q38003175 | ||
| Current insights into neutrophil homeostasis | Q38035453 | ||
| Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway | Q38046606 | ||
| Recent therapeutic advances and insights of recurrent glioblastoma multiforme | Q38070514 | ||
| Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. | Q38081572 | ||
| Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review | Q38090286 | ||
| Epidermal growth factor receptor as a therapeutic target in glioblastoma | Q38098098 | ||
| FTY720 for cancer therapy (Review). | Q38150194 | ||
| Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme | Q38179992 | ||
| Sphingosine 1-phosphate in blood: function, metabolism, and fate | Q38224523 | ||
| Tumor-associated macrophages as major players in the tumor microenvironment | Q38240110 | ||
| Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients | Q38259088 | ||
| Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme | Q38262132 | ||
| Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. | Q38277068 | ||
| The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity | Q38294399 | ||
| Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. | Q38340109 | ||
| New strategies in glioblastoma: exploiting the new biology | Q38351403 | ||
| Human cytomegalovirus riding the cell cycle. | Q38379991 | ||
| Overcoming the blood-brain tumor barrier for effective glioblastoma treatment | Q38384505 | ||
| Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival | Q38480274 | ||
| The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression | Q38540262 | ||
| Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy | Q38599484 | ||
| The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. | Q38605925 | ||
| GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates | Q38605928 | ||
| Growth differentiation factor 15 promotes cell viability, invasion, migration, and angiogenesis in human liver carcinoma cell line HepG2. | Q38717948 | ||
| FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing. | Q38735557 | ||
| The challenges associated with molecular targeted therapies for glioblastoma | Q38743460 | ||
| Oncolytic Virotherapy for the Treatment of Malignant Glioma | Q38749871 | ||
| Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression | Q38754716 | ||
| Human cytomegalovirus may promote tumour progression by upregulating arginase-2. | Q38760685 | ||
| Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium | Q38791716 | ||
| Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543. | Q38802701 | ||
| Fingolimod provides long-term protection in rodent models of cerebral ischemia | Q38806688 | ||
| Sphingosine 1-phosphate (S1P) induced interleukin-8 (IL-8) release is mediated by S1P receptor 2 and nuclear factor κB in BEAS-2B cells | Q38813531 | ||
| Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response | Q38820639 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype | Q38868808 | ||
| Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells | Q38871772 | ||
| Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia | Q38876000 | ||
| FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells | Q38879206 | ||
| Intratumoral histologic heterogeneity of gliomas. A quantitative study | Q38882699 | ||
| Role of ketogenic metabolic therapy in malignant glioma: A systematic review | Q38889019 | ||
| GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways. | Q38904689 | ||
| Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer | Q38905385 | ||
| Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype | Q38906823 | ||
| Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention? | Q38908560 | ||
| A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells. | Q38923568 | ||
| Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation | Q38953409 | ||
| Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration | Q38955639 | ||
| Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway | Q38958515 | ||
| Cyclooxygenase-2 in glioblastoma multiforme | Q38969912 | ||
| Inhibition of glioma progression by a newly discovered CD38 inhibitor. | Q38972612 | ||
| In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models | Q38978515 | ||
| Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes. | Q38978590 | ||
| Glutamate and α-ketoglutarate: key players in glioma metabolism | Q38983559 | ||
| Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells | Q39041611 | ||
| Toward Personalized Targeted Therapeutics: An Overview | Q39044141 | ||
| Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? | Q39909777 | ||
| Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection | Q39950845 | ||
| The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation | Q39959907 | ||
| Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. | Q39972447 | ||
| Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines | Q39972860 | ||
| Human cytomegalovirus inhibits cytokine-induced macrophage differentiation | Q39992541 | ||
| Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population | Q39997413 | ||
| Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo | Q39997572 | ||
| Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics | Q40011425 | ||
| Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages | Q40029162 | ||
| GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro | Q40032613 | ||
| S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. | Q40033973 | ||
| Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. | Q40102693 | ||
| Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line | Q40104116 | ||
| Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness | Q40115765 | ||
| Distribution of neurotensin and its receptor in the central nervous system | Q40134265 | ||
| The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells | Q40212349 | ||
| Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination | Q40241735 | ||
| Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection | Q40274640 | ||
| Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13. | Q40276413 | ||
| S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population. | Q40279381 | ||
| Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. | Q40280838 | ||
| Neurotensin enhances nitric oxide generation via the JAK2-STAT1 pathway in murine macrophage Raw264.7 cells during costimulation with LPS and IFNgamma | Q40300178 | ||
| Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice model | Q40366512 | ||
| A paired comparison between glioblastoma "stem cells" and differentiated cells | Q40373080 | ||
| Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines | Q40384186 | ||
| Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus | Q40444834 | ||
| Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line | Q40514985 | ||
| Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas | Q40554806 | ||
| Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells. | Q40608026 | ||
| Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation | Q40609266 | ||
| FTY720 attenuates excitotoxicity and neuroinflammation. | Q40613316 | ||
| CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells | Q40619963 | ||
| Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. | Q40673595 | ||
| EGFR, p53, IDH-1 and MDM2 immunohistochemical analysis in glioblastoma: therapeutic and prognostic correlation. | Q40709419 | ||
| Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. | Q40722521 | ||
| The immune modulator FTY720 targets sphingosine 1-phosphate receptors | Q40736684 | ||
| Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes | Q40778287 | ||
| Lysophospholipids increase interleukin-8 expression in ovarian cancer cells | Q40809174 | ||
| Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study | Q40869992 | ||
| Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate | Q40870274 | ||
| Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. | Q40875274 | ||
| Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function. | Q40925445 | ||
| Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis. | Q40927773 | ||
| Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma | Q41074007 | ||
| Sphingosine 1-phosphate Receptor 2 Signaling Suppresses Macrophage Phagocytosis and Impairs Host Defense against Sepsis | Q41096093 | ||
| Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells | Q41130088 | ||
| The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1. | Q41221061 | ||
| CD133 Regulates IL-1β Signaling and Neutrophil Recruitment in Glioblastoma | Q41288638 | ||
| Stimulatory effects of human cytomegalovirus tegument protein pp71 lead to increased expression of CCL2 (monocyte chemotactic protein-1) during infection | Q41356756 | ||
| A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme | Q41481825 | ||
| Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect | Q41490097 | ||
| Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses | Q41581885 | ||
| Prognostic role of neutrophil lymphocyte ratio in patients with glioma | Q41708897 | ||
| HCMV induces dysregulation of glutamate uptake and transporter expression in human fetal astrocytes | Q41712134 | ||
| The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis | Q41770473 | ||
| Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma. | Q52846347 | ||
| Cytomegalovirus-specific regulatory and effector T cells share TCR clonality--possible relation to repetitive CMV infections. | Q52891818 | ||
| The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation. | Q52904194 | ||
| SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo. | Q52955080 | ||
| Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. | Q53175353 | ||
| Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent. | Q53186527 | ||
| Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia. | Q53236986 | ||
| Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis. | Q53274535 | ||
| CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. | Q53306828 | ||
| Chemokines in vascular remodeling. | Q53555481 | ||
| The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. | Q53579438 | ||
| Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. | Q53621449 | ||
| Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein. | Q53650569 | ||
| Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification. | Q53838239 | ||
| Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. | Q54321271 | ||
| FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway. | Q54334399 | ||
| Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9. | Q54392759 | ||
| Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma | Q54402893 | ||
| Differential responses of human microglia and blood-derived myeloid cells to FTY720. | Q54412239 | ||
| Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury. | Q54577209 | ||
| SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway. | Q55027066 | ||
| Glioblastoma multiforme stem cells. | Q55084777 | ||
| Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme. | Q55462188 | ||
| IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas. | Q55463659 | ||
| Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. | Q55463916 | ||
| Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. | Q55475169 | ||
| Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. | Q55475809 | ||
| Signal transduction of sphingosine-1-phosphate G protein-coupled receptors. | Q55513682 | ||
| Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: Antiviral implications | Q56965208 | ||
| Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes | Q56965230 | ||
| Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization | Q57200899 | ||
| Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression | Q59466639 | ||
| Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis | Q30417313 | ||
| Characterization of a sphingosine 1-phosphate receptor antagonist prodrug | Q30425227 | ||
| Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages | Q30436091 | ||
| Virus-encoded homologs of cellular interleukin-10 and their control of host immune function | Q30436621 | ||
| Chemokines as mediators of neovascularization | Q30438032 | ||
| Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway | Q30441092 | ||
| Diverse roles of neurotensin agonists in the central nervous system | Q30456105 | ||
| Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host | Q30478992 | ||
| Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma | Q30491742 | ||
| Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. | Q30565662 | ||
| Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties | Q30572687 | ||
| Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial | Q30789784 | ||
| Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data. | Q30794277 | ||
| SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells | Q31942539 | ||
| FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells | Q31952928 | ||
| In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors | Q31970611 | ||
| Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor | Q33266079 | ||
| FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. | Q33271908 | ||
| Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide | Q33341259 | ||
| Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial | Q33359703 | ||
| A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma. | Q33391296 | ||
| Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility | Q33410786 | ||
| Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study | Q33432135 | ||
| HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation | Q33572274 | ||
| Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1. | Q33607086 | ||
| Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells | Q33664082 | ||
| Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. | Q33761585 | ||
| Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor. | Q33769389 | ||
| Induced Regulatory T Cells Superimpose Their Suppressive Capacity with Effector T Cells in Lymph Nodes via Antigen-Specific S1p1-Dependent Egress Blockage | Q33770196 | ||
| Genetic instability and darwinian selection in tumours | Q33804007 | ||
| Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus | Q33810440 | ||
| Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis | Q33810559 | ||
| The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages | Q33826894 | ||
| Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes | Q33842393 | ||
| Neurotensin increases endogenous glutamate release in rat cortical slices | Q62965080 | ||
| Neuropeptides modulating macrophage function | Q70185582 | ||
| Neurotensin stimulates neutrophil adherence to bronchial epithelial cells in vitro | Q71040678 | ||
| Neurotensin modulates human neutrophil locomotion and phagocytic capability | Q71792602 | ||
| Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation | Q73414391 | ||
| Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production | Q73426568 | ||
| Immunosuppressive action of FTY720 for renal allograft a rat model | Q74617211 | ||
| Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model | Q74617278 | ||
| Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3 | Q79853765 | ||
| FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model | Q79959742 | ||
| Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice | Q80261117 | ||
| Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting | Q80981625 | ||
| Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo | Q81215279 | ||
| CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis | Q82283387 | ||
| MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts | Q82414820 | ||
| Latency and reactivation of human cytomegalovirus | Q83946800 | ||
| The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro | Q84108192 | ||
| FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice | Q84220581 | ||
| GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells | Q84578298 | ||
| The subpopulation of microglia sensitive to neurotransmitters/neurohormones is modulated by stimulation with LPS, interferon-γ, and IL-4 | Q87248985 | ||
| Controlled release of sphingosine-1-phosphate agonist with gelatin hydrogels for macrophage recruitment | Q87412863 | ||
| Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. | Q41876583 | ||
| Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial. | Q41926865 | ||
| Modeling cytomegalovirus infection in mouse tumor models | Q41929176 | ||
| Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression | Q41966417 | ||
| Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis | Q42011721 | ||
| Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. | Q45086529 | ||
| Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival | Q45327856 | ||
| The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages | Q45720263 | ||
| Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers | Q45735279 | ||
| Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis | Q45740172 | ||
| Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions. | Q45924633 | ||
| The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. | Q45956195 | ||
| Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. | Q46017179 | ||
| Neurotensin enhances IL-1 production by activated alveolar macrophages. | Q46030923 | ||
| Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy. | Q46127268 | ||
| Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation | Q46143632 | ||
| Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy | Q46202289 | ||
| Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience. | Q46231452 | ||
| PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling | Q46365844 | ||
| S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing | Q46399943 | ||
| Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme | Q46412809 | ||
| Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice | Q46613202 | ||
| Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues | Q46668631 | ||
| Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma. | Q46709590 | ||
| Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. | Q46751827 | ||
| Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells | Q46759430 | ||
| Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression | Q46820182 | ||
| Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. | Q46869214 | ||
| Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization | Q46882679 | ||
| A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma | Q46979728 | ||
| Anorexia and weight loss in glioma patients | Q47187804 | ||
| Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration | Q47806925 | ||
| GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand | Q47897710 | ||
| Cancer-promoting mechanisms of tumor-associated neutrophils | Q47920259 | ||
| Is there a change in cytomegalovirus seroepidemiology in Spain? | Q47974547 | ||
| Soluble human leukocyte antigen G5 polarizes differentiation of macrophages toward a decidual macrophage-like phenotype. | Q48022161 | ||
| GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5/TGF-βRII heterodimer | Q48219910 | ||
| Production and neuroprotective functions of fractalkine in the central nervous system | Q48258224 | ||
| Sphk1 mediates neuroinflammation and neuronal injury via TRAF2/NF-κB pathways in activated microglia in cerebral ischemia reperfusion | Q48268373 | ||
| The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients | Q48298035 | ||
| Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity? | Q48301491 | ||
| Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-beta release. | Q48382115 | ||
| Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages | Q48428929 | ||
| Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome | Q48573837 | ||
| Radiogenomics to characterize regional genetic heterogeneity in glioblastoma | Q48582092 | ||
| Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells. | Q48649561 | ||
| Peritumoral angiogenesis around primary and metastatic brain neoplasms. Morphometric analysis | Q48730491 | ||
| Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion | Q48819256 | ||
| CD4+Foxp3- type 1 regulatory T cells in glioblastoma multiforme suppress T cell responses through multiple pathways and are regulated by tumor-associated macrophages. | Q50617004 | ||
| High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression. | Q50981100 | ||
| The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling. | Q51320013 | ||
| Sphingosine-1-phosphate-activated TRPC1 channel controls chemotaxis of glioblastoma cells. | Q51497442 | ||
| The Effect of Sphingosine 1-Phosphate/Sphingosine 1-Phosphate Receptor on Neutrophil Function and the Relevant Signaling Pathway. | Q51640897 | ||
| Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis. | Q51676055 | ||
| A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma. | Q52145569 | ||
| S1PR5 is pivotal for the homeostasis of patrolling monocytes. | Q52639389 | ||
| Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p | Q36493809 | ||
| Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169 | Q36499722 | ||
| Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines | Q36523245 | ||
| Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma | Q36523499 | ||
| The role of neurotensin in central nervous system pathophysiology: what is the evidence? | Q36544566 | ||
| Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo | Q36545028 | ||
| Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors. | Q36557481 | ||
| Neurotensin and growth of normal and neoplastic tissues | Q36563759 | ||
| Epidemiology and molecular pathology of glioma | Q36577353 | ||
| The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer | Q36592451 | ||
| The multifaceted roles of chemokines in malignancy | Q36611120 | ||
| Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma | Q36650859 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| GDF15 promotes EMT and metastasis in colorectal cancer | Q36729546 | ||
| Molecular heterogeneity of glioblastomas: does location matter? | Q36729562 | ||
| Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in Monocytes | Q36736415 | ||
| Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins | Q36736892 | ||
| Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal | Q36804936 | ||
| Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling | Q36873593 | ||
| Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment. | Q36900640 | ||
| The S phase of the cell cycle and its perturbation by human cytomegalovirus | Q36901744 | ||
| A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells | Q36907370 | ||
| Control of glioma cell migration and invasiveness by GDF-15 | Q36946604 | ||
| Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A | Q36981029 | ||
| Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness | Q36982983 | ||
| Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme | Q37022369 | ||
| Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro | Q37025429 | ||
| Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage | Q37040044 | ||
| Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells | Q37081881 | ||
| A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association | Q37085029 | ||
| Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas | Q37109246 | ||
| The human cytomegalovirus. | Q35143349 | ||
| Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients | Q35154148 | ||
| Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells | Q35214798 | ||
| The two faces of interferon-γ in cancer | Q35269015 | ||
| Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction | Q35351861 | ||
| Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. | Q35476157 | ||
| Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules | Q35501532 | ||
| The role of metabolic therapy in treating glioblastoma multiforme | Q35519662 | ||
| Human cytomegalovirus gene expression in long-term infected glioma stem cells. | Q35535809 | ||
| Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer. | Q35568516 | ||
| Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation | Q35570705 | ||
| Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer. | Q35578796 | ||
| Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations | Q35748846 | ||
| Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma | Q35759682 | ||
| Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response | Q35779256 | ||
| Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice | Q35786286 | ||
| Generation and metabolism of bioactive sphingosine-1-phosphate | Q35839009 | ||
| Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma | Q35845241 | ||
| CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5 | Q35911313 | ||
| A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy | Q35966272 | ||
| VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors | Q35977376 | ||
| Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice | Q36012100 | ||
| Genetic analysis of cytomegalovirus in malignant gliomas | Q36086786 | ||
| Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting | Q36122563 | ||
| Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. | Q36178557 | ||
| Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence | Q36214992 | ||
| Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis | Q36281674 | ||
| Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma | Q36336070 | ||
| Regulation of tissue infiltration by neutrophils: role of integrin α3β1 and other factors | Q36342909 | ||
| Chronic reactive gliosis following regulatory T cell depletion during acute MCMV encephalitis | Q36348385 | ||
| Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients | Q36349348 | ||
| Cancer CXC chemokine networks and tumour angiogenesis | Q36410717 | ||
| Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. | Q36421073 | ||
| The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment | Q36473213 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | 7219-7270 | |
| P577 | publication date | 2018-01-09 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection. | |
| P478 | volume | 9 |
| Q98166036 | Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools |
| Q89552038 | Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks |
| Q58766021 | The Pathophysiology of Post-Traumatic Glioma |
Search more.